Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 26;1(9):e8.
doi: 10.1038/psp.2012.8.

CPT: Pharmacometrics and Systems Pharmacology

Piet H van der Graaf  1
Affiliations

CPT: Pharmacometrics and Systems Pharmacology

Piet H van der Graaf. CPT Pharmacometrics Syst Pharmacol. .

Abstract

Welcome to the first issue of CPT: Pharmacometrics and Systems Pharmacology (CPT:PSP), a new journal from the American Society for Clinical Pharmacology and Therapeutics. CPT:PSP is a cross-disciplinary journal devoted to publishing advances in quantitative, model-based approaches as applied in pharmacology, (patho)physiology, and disease to aid the discovery, development, and utilization of human therapeutics. The emphasis of CPT:PSP will be on the application of modeling and simulation and the impact of Pharmacometrics and Systems Pharmacology on the discovery and development of innovative therapies.CPT: Pharmacometrics & Systems Pharmacology (2012) 1, e8; doi:10.1038/psp.2012.8; advance online publication 26 September 2012.

PubMed Disclaimer

Figures

Figure 1
Figure 1
An integrated view of model-based drug discovery and development. CPT: Pharmacometrics and Systems Pharmacology (CPT:PSP) welcomes contributions of research across the whole spectrum of Pharmacometrics and Systems Pharmacology, with emphasis on application and impact on innovation of therapeutics. The common focus will be on quantitative methods that improve our understanding of pharmacology and therapeutics in humans. This is based on Figure 3 in the work of van der Graaf and Benson, which was further developed with input from Peter Milligan (Pfizer) and redrawn with permission from Pharmaceutical Research. PD, pharmacodynamics; PK, pharmacokinetics; PKPD, pharmacokinetics–pharmacodynamics.
See this image and copyright information in PMC

References

    1. Ette E.I., &, Williams P.J. John Wiley & Sons, Inc., Hoboken, New Jersey; 2007. Pharmacometrics: The Science of Quantitative Pharmacology.
    1. Barrett J.S., Fossler M.J., Cadieu K.D., &, Gastonguay M.R. Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings. J. Clin. Pharmacol. 2008;48:632–649. - PubMed
    1. Lalonde R.L.et al. Model-based drug development Clin. Pharmacol. Ther 8221–32.2007 - PubMed
    1. Manolis E., &, Herold R. Pharmacometrics for regulatory decision making: status and perspective. Clin. Pharmacokinet. 2011;50:625–626. - PubMed
    1. Lee J.Y.et al. Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008 Clin. Pharmacokinet 50627–635.2011 - PubMed